Hims & Hers Health, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4330001060
USD
22.02
-2.96 (-11.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
617.82
598.98
544.83
586.01
481.14
401.56
315.65
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
617.82
598.98
544.83
586.01
481.14
401.56
315.65
Raw Material Cost
271.55
233.77
195.13
218.35
117.66
131.19
100.49
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
292.67
306.46
278.90
279.82
340.72
226.04
184.85
Other Expenses
4.10
4.06
3.78
2.99
0.00
2.11
1.87
Total Expenditure (Excl Depreciation)
605.18
580.80
511.88
528.09
458.38
378.32
303.99
Operating Profit (PBDIT) excl Other Income
12.6
18.2
33
57.9
22.799999999999997
23.2
11.7
Other Income
6.36
8.04
6.13
2.60
3.69
1.22
2.39
Operating Profit (PBDIT)
37.09
43.89
49.55
68.80
32.52
28.83
17.70
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
-0.64
-13.99
-6.23
-0.02
-4.16
-0.86
-0.63
Gross Profit (PBDT)
346.27
365.21
349.71
367.66
363.48
270.37
215.16
Depreciation
18.09
17.67
10.46
8.28
6.06
4.38
3.64
Profit Before Tax
18.35
12.22
32.85
60.49
22.29
23.59
13.42
Tax
-2.25
-3.55
-9.65
11.01
-3.73
-51.99
0.13
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
20.60
15.77
42.51
49.48
26.02
75.59
13.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
20.60
15.77
42.51
49.48
26.02
75.59
13.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
20.60
15.77
42.51
49.48
26.02
75.59
13.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
540.93
580.98
562.70
549.26
476.72
440.05
361.97
Earnings per share (EPS)
0.09
0.06
0.17
0.2
0.11
0.32
0.06
Diluted Earnings per share
0.09
0.06
0.17
0.2
0.11
0.32
0.06
Operating Profit Margin (Excl OI)
2.05%
3.03%
6.05%
9.88%
4.73%
5.79%
3.69%
Gross Profit Margin
5.9%
4.99%
7.95%
11.74%
5.89%
6.97%
5.41%
PAT Margin
3.33%
2.63%
7.8%
8.44%
5.41%
18.82%
4.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 28.41% vs 95.09% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is -20.77% vs 2,066.67% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 6.60% vs 572.13% in Dec 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of Hims & Hers Health, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
617.82
373.08
244.74
65.60%
Other Operating Income
0.00
0.00
0.00
Total Operating income
617.82
373.08
244.74
65.60%
Raw Material Cost
271.55
253.62
17.93
7.07%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
2.73
-2.73
-100.00%
Selling and Distribution Expenses
292.67
66.78
225.89
338.26%
Other Expenses
4.10
-0.27
4.37
1,618.52%
Total Expenditure (Excl Depreciation)
605.18
320.40
284.78
88.88%
Operating Profit (PBDIT) excl Other Income
12.64
52.68
-40.04
-76.01%
Other Income
6.36
0.60
5.76
960.00%
Operating Profit (PBDIT)
37.09
57.42
-20.33
-35.41%
Interest
0.00
2.73
-2.73
-100.00%
Exceptional Items
-0.64
-10.40
9.76
93.85%
Gross Profit (PBDT)
346.27
119.46
226.81
189.86%
Depreciation
18.09
4.15
13.94
335.90%
Profit Before Tax
18.35
40.15
-21.80
-54.30%
Tax
-2.25
10.37
-12.62
-121.70%
Provisions and contingencies
0
0
0.00
Profit After Tax
20.60
29.78
-9.18
-30.83%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
20.60
29.78
-9.18
-30.83%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
20.60
29.78
-9.18
-30.83%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
540.93
1,085.30
-544.37
-50.16%
Earnings per share (EPS)
0.09
1.61
-1.52
-94.41%
Diluted Earnings per share
0.09
1.61
-1.52
-94.41%
Operating Profit Margin (Excl OI)
2.05%
14.12%
0.00
-12.07%
Gross Profit Margin
5.90%
11.87%
0.00
-5.97%
PAT Margin
3.33%
7.98%
0.00
-4.65%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 61.78 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 3.14% vs 9.95% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 28.41% vs 95.09% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.06 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 30.38% vs -62.82% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -20.77% vs 2,066.67% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.07 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -14.25% vs -17.51% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 6.60% vs 572.13% in Dec 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.05%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024